Optimal Timing of Colostomy and Enterostomy Reversal: Insights from A 15-Year Retrospective Analysis
Comprehensive medicine, cilt.17, sa.4, ss.279-285, 2025 (TRDizin)
- Yayın Türü: Makale / Tam Makale
- Cilt numarası: 17 Sayı: 4
- Basım Tarihi: 2025
- Doi Numarası: 10.14744/cm.2025.07769
- Dergi Adı: Comprehensive medicine
- Derginin Tarandığı İndeksler: TR DİZİN (ULAKBİM)
- Sayfa Sayıları: ss.279-285
- Açık Arşiv Koleksiyonu: AVESİS Açık Erişim Koleksiyonu
- Sağlık Bilimleri Üniversitesi Adresli: Evet
Özet
Objective: This study aimed to evaluate the impact of optimal timing of enterostomy (particularly ileostomy) and colostomy closures on postoperative com- plications. The goal was to compare early versus late closures to inform surgical strategies and improve patient outcomes. Materials and Methods: Data from 474 patients who underwent ostomy closure between 2008 and 2023 were retrospectively analyzed. Based on prior litera- ture, enterostomy patients were grouped as early (<12 weeks) or late (>12 weeks), and colostomy patients as early (<12 weeks), intermediate (13–20 weeks), or late (>20 weeks). Only patients with complete clinical records were included. Results: Among 366 patients with enterostomy closure, 27.5% (n=101) underwent closure within 12 weeks, while 72.4% (n=265) had closure after 12 weeks. Overall complication rate was 8.4%, with serosal injury (58.1%) and perforation (38.7%) being the most frequent. Late closure was significantly associated with malignant indications (OR = 7.208), preoperative rectoscopy (OR=2.063), and adjuvant therapy (OR=1.735). In 108 patients with colostomy closure, the compli- cation rate was 23.2%, with serosal damage (52.0%) and perforation (40.0%) being most common. Malignancy was less common in patients closed within 12 weeks, but significantly higher in the >20-week group (p<0.001). Malignancy increased the risk of delayed closure by 4.9 times according to logistic regression. Conclusion: Optimal timing of ostomy closure is critical, especially in malignancy-related cases. Delayed closure is linked to increased complication rates. When early closure is applied to selected low-risk patients, outcomes may improve. Surgical timing should be guided by comorbidities, underlying disease, and oncologic treatment history.